Pneumonitis related to venlafaxine

Psychosomatics

Volumn 49, Issue 1, 2008, Pages 84-85

  Vázquez, M José Martín ^a   Quevedo, Blanca Carretero ^a  

^a HOSPITAL SON LLÀTZER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CORTICOSTEROID; LEVOFLOXACIN; LEVOTHYROXINE; MIRTAZAPINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; ASTHENIA; BRONCHUS HYPERREACTIVITY; CASE REPORT; CHOLESTASIS; CLINICAL EXAMINATION; COUGHING; DEPRESSION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HUMAN; LASSITUDE; PNEUMONIA; THORAX PAIN; TREATMENT OUTCOME;

EID: 37549023052     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.49.1.84     Document Type: Letter

References (5)

1. Fleisch MC, Blauer F, Gubler JGH, et al: Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment. Eur Respir J 2000; 15:205-208
2. Drent M, Singh S, Gorgels AP, et al: Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine. Am J Respir Crit Care Med 2003; 167:958-961
3. Reeve HL, Nelson DP, Archer SL, et al: Effect of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology. Am Rev Respir Dis 1989; 139:247-249
4. MacLean Margaret R: Endothelin-1 and serotonic mediators of primary and secondary pulmonary hypertension. J Lab Clin Med 1999; 134:105-114
5. Horsmans Y, De Clercq M, Sempoux C: Venlafaxine-associated hepatitis (letter). Ann Intern Med 1999; 130:944